
India reduces prices of 543 cancer drugs by up to 93%
The National Pharmaceutical Pricing Authority in India has announced a significant reduction in the prices of 543 cancer drugs, aiming to improve affordability for patients.
Background
Access to affordable healthcare, particularly life-saving medications, remains a critical challenge in many parts of the world. Governments and health organizations often grapple with balancing pharmaceutical innovation with public accessibility. India, with its large population, frequently addresses drug pricing to ensure essential medicines are within reach for its citizens.
Quorum · collective opinions
Price Reduction for Cancer Drugs
First report 11h agoLast update 11h agoA substantial price cut of up to 93% for 543 cancer drugs has been implemented by the National Pharmaceutical Pricing Authority.
iWitness comments
No comments yet — be the first to weigh in.